Enabling precision medicine
Olink Proteomics at a glance
Olink develops and markets its unique technology for protein analysis in human protein biomarker research. Olink’s proprietary Proximity Extension Assay (PEA) technology enables researchers to analyze large numbers of proteins with high-throughput analysis, exceptional data quality, and minimal sample consumption. This enables research which previously could not be done and lowers costs. The technology drives precision medicine by improving the understanding of the interaction of proteins and human disease.
Year acquired
Sector
Revenue
Location
Employees
Website
Investment themes
Contact
The challenges we face
We currently suffer from ineffective medication due to a lack of understanding of the biology of diseases. The shift from the "one size fits all" approach to precision medicine is a colossal challenge for science. Delivering the right treatment, to the right patient at the appropriate time requires developing protein biomarker panels to improve our understanding of human biology and optimize the development of new drugs and treatments.
of patients receive no benefit from treatment with top 10 best-selling drugs in the world.
of OECD GDP is spent on healthcare
How does Olink help?
Reality today
We do not understand the biology of many leading diseases—in particular the role of proteins—which prevents us from developing effective medication and delivering precision treatment.
Olink approach
Olink’s proprietary Proximity Extension Assay (PEA) technology enables researchers to efficiently analyze large numbers of proteins with high throughput analysis, advancing our understanding of protein interactions in human diseases and our ability to develop new therapies.
Aspirational future
Deeper understanding of human biology and disease allows us to develop and deliver the most effective treatments for patients.
Who is impacted?
Researchers are impacted directly through more effective tools to understand human biology. Patients are impacted indirectly through breakthroughs in treatments.
What are the impact considerations?
Additionality
By providing a truly unique technology to the market, Olink makes a major contribution to the research enabling advancements in precision medicine.
Risks
Olink’s impact depends in part on how its customers in academia and biopharma choose to use its tools. Olink can engage customers to help ensure that the research it enables translates into treatment innovations and eventually patient outcomes.
SDG alignments
